Agency Information Collection Activities; Proposed Collection; Comment Request; Health Care Providers’ Understanding of Opioid Analgesic Abuse Deterrent Formulations
2019-958 OO Notice Agency Information Collection Activities Proposed Collection Comment Request Health Care Providers’ Understanding of Opioid Analgesic Abuse Deterrent Formulations OPEN
2020-02-28
FDA-2019-N-5973-0004
05:00:00
https://api.regulations.gov/v4/comments/FDA-2019-N-5973-0004
Anonymous
Anonymous
I believe Phase 2 should include more pharmacists than 10% ratio. Also practitioners chosen should be based on greater prescribing habits. Those practitioners who are the larger rate of treating Chronic Non-Cancer pain with ADF Opioid should be the target of information gathering.